Non-vector transmission of dengue and other mosquito-borne flaviviruses

Dengue Bulletin

Volumn 29, Issue , 2005, Pages 18-31

  Chen, Lin H ^a   Wilson, Mary E ^a  

^a MOUNT AUBURN HOSPITAL   (United States)

Author keywords

Dengue; Flavivirus; Virus transmission; West Nile virus

Indexed keywords

VIRUS VECTOR;

ARTHRALGIA; DENGUE; DENGUE VIRUS; EPIDEMIC ENCEPHALITIS; EXPOSURE; FEVER; FLAVIVIRUS; HEMORRHAGIC FEVER; HUMAN; INFECTION RISK; MOSQUITO; NONHUMAN; PROBABILITY; RASH; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

DENGUE VIRUS; FLAVIVIRIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MOSQUITO-BORNE VIRUSES; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 33646191400     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Burke DS and Monath TP. Flaviviruses. In: Knipe DM, Howley, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 4th ed. Vol.1. Philadelphia: Lippincott Williams & Wilkins, 2001: pp.1043-1125.
2. Mackenzie JS, Gubler DJ and Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004; 10(12 Suppl): S98-109.
3. Gea-Banacloche J, Johnson RT, Bagic A, Butman JA, Murray PR and Agrawal AG. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med. 2004; 140(7): 545-553.
4. Molina-Cruz A, Gupta L, Richardson J, Bennett K, Black W IV and Barillas-Mury C. Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti. Am J Trop Med Hyg. 2005; 72(5): 631-637.
5. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG and Frankel SS. Human skin Langerhans cells are targets of dengue virus infection. Nat Med. 2000; 6(7): 816-820.
6. Marovich M, Grouard-Vogel G, Louder M, Eller M, Sun W, Wu SJ, Putvatana R, Murphy G, Tassaneetrithep B, Burgess T, Birx D, Hayes C, Schlesinger-Frankel S and Mascola J. Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc. 2001; 6(3): 219-224.
7. Higgs S, Schnieder BS, Vanlandingham DL, Klinger KA and Gould EA. Nonviremic transmission of West Nile virus. Proc Nat Acad Sci. 2005; 102(25): 8871-8874.
8. Vanlandingham DL, Schneider BS, Klingler K, Fair J, Beasley D, Huang J, Hamilton P and Higgs S. Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus. Am J Trop Med Hyg. 2004; 71(1): 120-123.
9. Kuno G. Transmission of arboviruses without involvement of arthropod vectors. Acta Virol. 2001; 45(3): 139-150.
10. Guzman H, Ding X, Xiao S-Y and Tesh RB. Duration of infectivity and RNA of Venezuelan equine encephalitis, West Nile, and yellow fever viruses dried on filter paper and maintained at room temperature. Am J Trop Med Hyg. 2005; 72(4): 474-477.
11. Wagner D, de With K, Huzly D, Hufert F, Weidmann M, Breisinger S, Eppinger S, Kern WV and Bauer TM. Nosocomial acquisition of dengue Emerg Infect Dis. 2004; 10(10): 1872-1873.
12. Nemes Z, Kiss G, Madarassi EP, Peterfi Z, Ferenczi E, Bakonyi T, Ternak G. Nosocomial transmission of dengue. Emerg Infect Dis. 2004; 10(10): 1880-1881.
13. de Wazieres B, Gil H, Vuitton DA and Dupond JL. Nosocomial transmission of dengue from a needlestick injury. Lancet. 1998; 351(9101): 498.
14. Hirsch JF, Deschamps C and Lhuillier M. Transmission métropolitaine d'une dengue par inoculation accidentelle hospitalière. Ann Med Interne (Paris). 1990; 141(7): 629.
15. Langgartner J, Audebert F, Schölmerich J, Gluck T. Dengue virus infection transmitted by needle stick injury. J Infect. 2002; 44(4): 269-270.
16. Rigau-Perez JG, Vorndam AV and Clark GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg. 2001; 64(1-2): 67-74.
17. Chye JK, Lim CT, Ng KB, Lim JMH, George R and Lam SK. Vertical transmission of dengue. Clin Infect Dis. 1997; 25(6): 1374-1377.
18. Kerdpanich A, Watanaveeradej V, Samakoses R, Chumnanvanakij S, Chulyamitporn T, Sumeksri P, Vuthiwong C, Kounruang C, Nisalak A and Endy T. Perinatal dengue infection. Southeast Asian J Trop Med Public Health. 2001; 32(3): 488-493.
19. Boussemart T, Babe P, Sibille G, Neyret C and Berchel C. Prenatal transmission of dengue: two new cases. J Perinatol. 2001; 21(4): 255-257.
20. Thaithumyanon P, Thisyakorn U, Deerojnawong J and Innis BL. Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman. Clin Infect Dis. 1994; 18(2): 248-249.
21. Chen LH and Wilson ME. Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect Dis. 2004; 39(6): e56-60.
22. De Silva AM, Dittus WP, Amerasinghe PH and Amerasinghe FP. Serologic evidence for an epizootic dengue virus infecting toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka. Am J Trop Med Hyg. 1999; 60(2): 300-306.
23. Low CG and Fairley NH. Laboratory and hospital infections with yellow fever in England. Br Med J. 1931: 125-128.
24. Berry GP and Kitchen SF. Yellow fever accidentally contracted in the laboratory: a study of seven cases. Am J Trop Med Hyg. 1931; 11: 365-434.
25. Cook GC. Fatal yellow fever contracted at the Hospital for Tropical Diseases, London, UK, in 1930. Trans R Soc Trop Med Hyg. 1994; 88(6): 712-713.
26. Findlay GM and MacCallum FO. Transmission of yellow fever virus to monkeys by mouth. J Pathol Bacteriol. 1939; 49: 53-61.
27. Niedrig M, Stolte N, Fuchs D, Hunsmann G and Stahl-Hennig C. Intra-nasal infection of macaques with yellow fever vaccine 17D: a novel and economical approach for YF vaccination in mice. Vaccine. 1999; 17(9-10): 1206-1210.
28. Monath TP. Yellow fever vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Pennsylvania: Saunders, 2004. pp. 1095-1176.
29. Findlay GM and Clarke LP. Infection with neurotropic yellow fever virus following instillation into the nares and conjunctival sac. J Pathol Bacteriol. 1935; xl: 55.
30. Bauer JH, Hudson NP. Passage of virus of yellow fever through skin. Am J Trop Med. 1928; 8: 371-378.
31. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. Morb Mortal Wkly Rep. 2002; 51(39): 877-878.
32. Centers for Disease Control and Prevention. Intrauterine West Nile Virus infection - United States, 2002. Morb Mortal Wkly Rep. 2002; 51(50): 1135-1136.
33. Centers for Disease Control and Prevention. Laboratory-acquired West Nile Virus infections - United States, 2002. Morb Mortal Wkly Rep. 2002; 51(50): 1133-1135.
34. Centers for Disease Control and Prevention. Update: West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. Morb Mortal Wkly Rep. 2004; 53(13): 281-284.
35. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL and Chamberland ME; West Nile virus transmission investigation team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003; 349(13): 1236-1245.
36. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, Pham SM, Zaki S, Lanciotti RS, Lance-Parker SE, DiazGranados CA, Winquist AG, Perlino CA, Wiersma S, Hillyer KL, Goodman JL, Marfin AA, Chamberland ME and Petersen LR; West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003; 348(22): 2196-2203.
37. Centers for Disease Control and Prevention. West Nile virus infection among turkey breeder farm workers - Wisconsin, 2002. Morb Mortal Wkly Rep. 2003; 52(42): 1017-1019.
38. Centers for Disease Control and Prevention. Possible dialysis-related West Nile virus transmission - Georgia, 2003. Morb Mortal Wkly Rep. 2004; 53(32): 738-739.
39. Tonry JH, Brown CB, Cropp CB, Co JK, Bennett SN, Nerurkar VR, Kuberski T and Gubler DJ. West Nile virus detection in urine. Emerg Infect Dis. 2005; 11(8):1294-1296.
40. Tonry JH, Xiao S-Y, Siirin M, Chen H, Travassos Da Rosa APA and Tesh RB. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg. 2005; 72(3): 320-324.
41. Tesh RB, Siirin M, Guzman H, Travassos da Rosa AP, Wu X, Duan T, Lei H, Nunes MR and Xiao SY. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis. 2005; 192(2): 287-295.
42. Odelola HA and Oduye O. West Nile virus infection of adult mice by oral route. Arch Virol. 1977; 54(3): 251-253.
43. Sbrana E, Tonry JH, Xiao S-Y, Travassos Da Rosa APA, Higgs S and Tesh RB. Oral transmission of West Nile Virus in a hamster model. Am J Trop Med Hyg. 2005; 72(3): 325-329.
44. Kerbo N, Donchenko I, Kutsar K, Vasilenko V. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Eurosurveillance. 2005; 10(6). (http://www.eurosurveilance./ew/2005/050623.asp#2, accessed 30 December 2005).
45. Halstead SB and Tsai TF. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Pennsylvania: Saunders, 2004. pp. 919-958.
46. Chaturvedi UC, Mathur A, Chandra A, Das SK, Tandon HO and Singh UK. Transplacental infection with Japanese encephalitits virus. J Infect Dis. 1980; 141(6): 712-715.
47. La Motte LC. Japanese encephalitis in bats during simulated hibernation. Am J Hyg. 1958; 67: 101-108.
48. Myint KS, Raengsakulrach B, Young GD, Gettayacamin M, Ferguson LM, Innis BL, Hoke CH Jr and Vaughn DW. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis vine. Am J Trop Med Hyg. 1999; 60(3): 338-342.
49. Larson EW, Dominik JW and Slone TW. Aerosol stability and respiratory infectivity of Japanese B encephalitis virus. Infect Immun. 1980; 30(2): 397-401.
50. Ramakrishna C, Desai A, Shankar SK, Chandramuki A and Ravi V. Oral immunization of mice with live Japanese encephalitis virus induces a protective immune response. Vaccine. 1999; 17(23-24): 3102-3108.
51. Mathur A, Khanna N, Kulshreshtha R, Maitra SC and Chaturvedi UC. Viruria during acute Japanese encephalitis virus infection. Int J Exp Pathol. 1995; 76(2): 103-109.
52. Phillpotts RJ, Brooks TJ and Cox CS. A simple device for the exposure of animals to infectious microorganisms by the airborne route. Epidemiol Infect. 1997; 118(1): 71-75.
53. Luby JP, Murphy FK, Gilliam JN, Kang CY and Frank R. Antigenuria in St Louis encephalitis. Am J Trop Med Hyg. 1980; 29(2): 265-268.
54. Nassar Eda S, Chamelet EL, Coimbra TL, de Souza LT, Suzuki A, Ferreira IB, da Silva MV, Rocco IM and Travassos da Rosa AP. Jungle yellow fever: clinical and laboratorial studies emphasizing viremia on a human case. Rev Inst Med Trop Sao Paulo. 1995; 37(4): 337-341.
55. Sharma S, Mathur A, Prakash V, Kulshreshtha R, Kumar R, Chaturvedi UC. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin Exp Immunol. 1991; 85(1): 85-89.
56. Ravi V, Desai AS, Shenoy PK, Satishchandra P, Chandramuki A, Gourie-Devi M. Persistence of Japanese encephalitis virus in the human nervous system. J Med Virol. 1993; 40(4): 326-329.
57. Gubler DJ, Suharyono W, Tan R, Abidin M and Sie A. Viremia in patients with naturally acquired dengue infection. Bull World Health Organ. 1981; 59(4): 623-630.
58. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000; 181(1): 2-9.
59. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA and Nisalak A. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997; 176(2): 322-330.
60. Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA and Rothman AL. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol. 2001; 63: 29-34.
61. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH and King CC. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003; 305(2): 330-338.
62. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003; 349(13): 1205-1206.
63. Campbell GL, Marfin AA, Lanciotti RS and Gubler DJ. West Nile virus. Lancet Infect Dis. 2002; 2(9): 519-529.
64. Southam CM and Moore AE. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg. 1954; 3(1): 19-50.
65. Napoli VM and McGowan JE Jr. How much blood is in a needlestick? J Infect Dis. 1987; 155(4): 828.
66. Biggerstaff BJ and Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002; 42(8): 1019-1026.
67. Goodnough LT, Brecher ME, Kanter MH and AuBuchon JP. Transfusion medicine. First of two parts - blood transfusion. N Eng J Med. 1999; 340(6): 438-447.
68. Macedo de Oliveira A, White KL, Leschinsky DP, Beecham BD, Vogt TM, Moolenaar RL, Perz JF and Safranek TJ. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med. 2005; 142(11): 898-902.
69. Wenzel RP and Edmond MB. Patient-to-patient transmission of hepatitis C virus. Ann Intern Med. 2005; 142(11): 940-941.
70. Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ and Torner JC. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis. 2003; 37(8): 1006-1013.
71. Lee JM, Botteman MV, Nicklasson L, Cobden D and Pashos CL. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Curr Med Res and Op. 2005; 21(5): 741-747.
72. Sagoe-Moses C, Pearson RD, Perry J and Jagger J. Risks to health care workers in developing countries. N Engl J Med. 2001; 354(7): 538-541.
73. Burke DS, Nisalak A, Johnson DE and Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988; 38(1): 172-180.
74. Solomon T. Flavivirus encephalitis. N Engl J Med. 2004; 351(4): 370-378.
75. Petersen LR and Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002; 137(3): 173-179.
76. Goldblum N. West Nile fever in the Middle East Proc 6th Int Cong. Trop Med Parasitol. 1959; 5: 112-125.
77. Halstead SB and Grosz CR. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg. 1962; 75: 190-201.
78. Monath TP and Tsai TF. St. Louis encephalitis: lessons from the last decade. Am J Trop Med Hyg. 1987; 37(3 Suppl): 40S-59S.